Follow the 플라즈맵 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 플라즈맵 has recorded 64 public disclosures. The latest transaction was disclosed on 29 April 2025 (Purchase). Among the most active insiders: 홍유동. All data is free.
61
Insider Decl.
n/a
Thresholds
n/a
31 ops.
Buy Volume
n/a
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Plasmapp is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on developing innovative solutions in the medical field.